혈액 투석 서비스 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the hemodialysis services market size was valued at USD 6.12 billion in 2025 and is estimated to grow from USD 6.44 billion in 2026 to reach USD 8.32 billion by 2031, at a CAGR of 5.25% during the forecast period (2026-2031).

This report is Segmented by Service Type (In-Center Hemodialysis, Home Hemodialysis, Nocturnal Hemodialysis, Others), End User (Dialysis Centers, Hospitals, Home Care Settings, Others), Indication (CKD, Acute Kidney Infections, Septic Shock, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Hemodialysis Services Market Trends and Insights

Rising ESRD Burden and CKD Progression

The hemodialysis services market is being pushed by a larger pool of patients with chronic kidney disease who eventually progress to ESRD and require ongoing renal replacement therapy. The Brazilian Dialysis Census 2024 recorded 172,585 patients on dialysis, which represented nearly 55% growth over the prior decade and showed how patient load continues to build across large treatment systems. The same census found that diabetes and hypertension each accounted for 29% of chronic kidney disease etiology, which shows that dialysis demand is still being fed by common long-duration metabolic disorders rather than isolated clinical episodes. This matters because patients who enter treatment later in the disease course often need more complex care, more clinical oversight, and longer treatment continuity, all of which raise the service intensity attached to each patient relationship. The hemodialysis services market also benefits from the fact that ESRD is not a short-cycle condition, so new patient additions tend to accumulate into a durable treatment census instead of rolling off quickly. As a result, rising CKD prevalence does not just widen the patient base, it also supports steadier utilization, more predictable scheduling, and stronger revenue visibility for operators that can handle higher-acuity care.

Expanding Medicare and National Dialysis Reimbursement Coverage

Reimbursement support remains one of the clearest growth supports for the hemodialysis services market because facility economics depend heavily on stable payment rules and frequent treatment billing. The CY 2026 ESRD Prospective Payment System final rule raised the Medicare base rate to USD 281.71 per treatment, which was USD 7.89 higher than in 2025. CMS also projected 2.2% growth in total payments to all ESRD facilities, with freestanding centers receiving a 2.2% increase and hospital-based facilities receiving a 1.5% increase, which reinforces the payment strength behind large outpatient networks. The rule also extended the training add-on payment adjustment for home and self-dialysis through 2026 and aligned the AKI dialysis payment rate at USD 281.71, which broadens the funded pathway for care outside the clinic. Even with that support, the early end of the ESRD Treatment Choices Model showed that payment incentives alone do not automatically shift care models when staffing, patient training, and infrastructure still limit execution. The hemodialysis services market therefore continues to gain from reimbursement breadth, while operators still need to pair that funding with clinical capacity and compliance performance under the ESRD Quality Incentive Program.

High Labor Intensity and Nurse Shortage Pressure

The most persistent brake on the hemodialysis services market is the labor intensity of treatment delivery, because dialysis care still depends on specialized nurses, nephrologists, technical staff, and strict supervision routines. The U.S. nephrology fellowship fill rate stood at 66% in 2024, which points to a pipeline problem at the same time that patient need continues to rise. The National Center for Health Workforce Analysis projected a 21% shortage of nephrologists by 2037 and a 10% shortage of registered nurses by 2027, with rural areas facing greater exposure to service gaps. Those shortages matter because new chair capacity cannot be fully utilized when a facility cannot staff shifts, train patients, or keep required oversight ratios in place. Telehealth and advanced practice providers can help at the margin, but Medicare's in-person requirements still limit how far those solutions can scale in routine use. The hemodialysis services market therefore faces a practical ceiling where demand remains strong, but labor shortages slow the pace at which operators can convert that demand into active treatment volume.

Other drivers and restraints analyzed in the detailed report include:

1. Shift Toward Home Hemodialysis and Remote Monitoring
2. Hemodiafiltration Upgrade Cycle in Installed Base Markets
3. Uneven Reimbursement for Home Modalities and Training Logistics

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In-center hemodialysis held 85.31% of hemodialysis services market share by service type in 2025, which shows how strongly the revenue base still depends on clinic-based treatment delivery. This segment remains dominant because dialysis centers provide the machines, trained clinical staff, water treatment systems, and emergency oversight that many patients with multiple comorbidities still need on a regular basis. The hemodialysis services market still leans toward in-center care because these facilities have been built over decades around predictable scheduling, payer familiarity, and strong procedural control. Nocturnal hemodialysis offers higher clearance volumes per session and has appeal for patients who want better daily-life flexibility, but it remains less common because longer chair occupancy changes the economics of each treatment slot. Other service types, including hybrid and home-linked modalities, continue to add smaller revenue streams in markets where public policy supports treatment outside the traditional center.

Home hemodialysis is the fastest-growing service type with an 8.38% CAGR from 2026 to 2031, which shows where future care redesign is concentrated inside the hemodialysis services market. Outset Medical received FDA 510(k) clearance in January 2026 for the next-generation Tablo hemodialysis system, which was also the first dialysis system cleared under the FDA's 2025 medical device cybersecurity requirements. The system is now deployed across more than 1,000 U.S. healthcare facilities, which suggests that providers are increasingly willing to back technology that supports simpler movement across care settings. That tighter regulatory bar may give an edge to vendors that can meet newer compliance standards, which could narrow supplier choice over time while strengthening the operating case for scalable home programs in the hemodialysis services market.

Complete Report Scope:

• By Service Type
  • In-Center Hemodialysis
  • Home Hemodialysis
  • Nocturnal Hemodialysis
  • Other Service Types
• By End User
  • Dialysis Centers
  • Hospitals
  • Home Care Settings
  • Other End Users
• By Indication
  • Chronic Kidney Disease (CKD)
  • Acute Kidney Infections
  • Septic Shock
  • Other Indications
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 38.22% of hemodialysis services market share in 2025, which made it the largest regional revenue base in the period. The United States supports this position through a Medicare ESRD entitlement that covers dialysis patients regardless of age, which gives the region a strong public reimbursement foundation. In CY 2026, the ESRD PPS base rate stands at USD 281.71 and is projected to generate nearly USD 6 billion in Medicare payments to nearly 7,600 ESRD facilities, which was a 2.2% increase from CY 2025. The analysis also showed that chain ownership remained very high among Medicare-certified dialysis facilities, which explains why scale, payer contracting, and operating efficiency remain central competitive tools in the hemodialysis services market. South America presents a different picture, where patient need continues to expand but lower public reimbursement creates a tighter investment environment for network growth.

Europe was the second-largest regional presence, with Germany and France identified as its anchor markets in the hemodialysis services market. Germany reflects a mature, high-penetration system backed by statutory health insurance, while France supports a large dialysis population through a nationally organized care structure. France's PLFSS 2026 legislation will shift dialysis financing from per-session payment to individualized weekly lump sums from January 2027, which is intended to encourage more home and autonomous dialysis use. That policy change matters across the wider hemodialysis services market in Europe because national health systems often influence provider investment decisions more directly than pure private pricing dynamics.

Asia-Pacific is the fastest-growing regional segment with a 7.65% CAGR through 2031, which gives the hemodialysis services market its strongest geographic expansion runway. The network expansion in underserved urban and semi-urban catchments, especially in large population countries, where access is still catching up with disease burden. This regional pattern is important because new clinic buildout in high-need areas can add volume quickly once reimbursement and supply conditions support regular service delivery. The Middle East and Africa still represent a smaller share of the hemodialysis services market, but public-private investment models and selective international expansion are gradually widening the regional care footprint.

1. Apollo Dialysis Clinics
2. B. Braun
3. Baxter
4. DaVita
5. DCDC Health Services
6. Dialysis Clinic, Inc.
7. Diaverum AB
8. Fresenius
9. Innovative Renal Care
10. Interwell Health
11. Mozarc Medical
12. NefroCenter Group
13. NephroPlus
14. Northwest Kidney Centers
15. Rogosin Institute
16. Satellite Healthcare, Inc.
17. U.S. Renal Care, Inc.
18. VitusCare

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising ESRD Burden and CKD Progression
  • 4.2.2 Expanding Medicare and National Dialysis Reimbursement Coverage
  • 4.2.3 Shift Toward Home Hemodialysis and Remote Monitoring
  • 4.2.4 Expansion of Center Networks in Urban and Tier-2 Catchments
  • 4.2.5 Hemodiafiltration Upgrade Cycle in Installed Base Markets
  • 4.2.6 Telehealth-Led Staffing Efficiency and Lower Chair Time Friction
• 4.3 Market Restraints
  • 4.3.1 High Labor Intensity and Nurse Shortage Pressure
  • 4.3.2 Vascular Access Failure and Rehospitalization Risk
  • 4.3.3 Water Treatment, Infection Control, and Compliance Overheads
  • 4.3.4 Uneven Reimbursement for Home Modalities and Training Logistics
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Bargaining Power of Suppliers
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Threat of New Entrants
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Service Type
  • 5.1.1 In-Center Hemodialysis
  • 5.1.2 Home Hemodialysis
  • 5.1.3 Nocturnal Hemodialysis
  • 5.1.4 Other Service Types
• 5.2 By End User
  • 5.2.1 Dialysis Centers
  • 5.2.2 Hospitals
  • 5.2.3 Home Care Settings
  • 5.2.4 Other End Users
• 5.3 By Indication
  • 5.3.1 Chronic Kidney Disease (CKD)
  • 5.3.2 Acute Kidney Infections
  • 5.3.3 Septic Shock
  • 5.3.4 Other Indications
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Apollo Dialysis Clinics
  • 6.3.2 B. Braun SE
  • 6.3.3 Baxter International Inc.
  • 6.3.4 DaVita Inc.
  • 6.3.5 DCDC Health Services
  • 6.3.6 Dialysis Clinic, Inc.
  • 6.3.7 Diaverum AB
  • 6.3.8 Fresenius Medical Care AG & Co. KGaA
  • 6.3.9 Innovative Renal Care
  • 6.3.10 Interwell Health
  • 6.3.11 Mozarc Medical
  • 6.3.12 NefroCenter Group
  • 6.3.13 NephroPlus
  • 6.3.14 Northwest Kidney Centers
  • 6.3.15 Rogosin Institute
  • 6.3.16 Satellite Healthcare, Inc.
  • 6.3.17 U.S. Renal Care, Inc.
  • 6.3.18 VitusCare

7 Market Opportunities & Future Outlook

• 7.1 White-Space and Unmet-Need Assessment